4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001415889-24-028661
Director bought 1,200,000 shares at an average $9.02 ($10,822,000)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TANG KEVIN Director | 2024-12-05 | Purchase | +300,000 | $8.91 | $2,673,000 | 7,529,500 | I: show line 1 in the form |
| TANG KEVIN Director | 2024-12-06 | Purchase | +400,000 | $9.01 | $3,604,000 | 7,929,500 | I: show line 2 in the form |
| TANG KEVIN Director | 2024-12-09 | Purchase | +500,000 | $9.09 | $4,545,000 | 8,429,500 | I: show line 3 in the form |
| Open-market purchases · 1,200,000 sh · avg $9.02 · $10,822,000 | |||||||
Loading xslF345X05/form4-12092024_091246.xml…